DRAGONPHARMA

DRAGONPHARMA has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €355,790 and a net result of -€8,675. Equity remains stable across the filed financial years (±1% per year). The computed 12-month bankruptcy probability is 0.2% (very low).